An interventional study of Hearing instrument in Hearing Loss, sponsored by Sonova AG. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2024-11-29.
Sponsored by Sonova AG · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn how hearing instruments perform in varying environmental settings in adults with hearing loss. The main questions it aims to answer are:
How do varying versions of hearing instrument features perform based on exposure to different environments? What is the hearing instrument user preference between varying versions of hearing instrument features?
Participants will be fit with hearing instruments in the lab, and asked to wear them for the duration of the study period in their home environment. Participants will be asked to answer questionnaires throughout the study period.
Exclusion Criteria:
Participants will wear hearing instruments for the duration of the study period. They will be asked to complete questionnaires about their environment and experience.
Device: Hearing instrument
Conventional, daily wear hearing instruments will be used in this study.
Hearing instrument feature performance
Accuracy of hearing instrument feature performance based on environmental sampling and subjective reporting
Time frame: From enrollment to the completion of data collection, approximately 6 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sonova AG